InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,465.82
(
-0.06%
)
US TECH 100
19,152.80
(
-0.12%
)
Dow Jones
39,147.71
(
0.09%
)
Brent Oil
85.00
(
0.96%
)
Bitcoin
61,216.21
(
-0.98%
)
Post# of 252368
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: DewDiligence post# 186412

Wednesday, 01/21/2015 8:01:08 PM

Wednesday, January 21, 2015 8:01:08 PM

Post# of 252368
Re: CNAT

I have to admit I don't really understand the rationale for CNAT's drug. It's usually a lack of proper apoptotic signaling that causes problems physiologically, and this drug seems to want to exacerbate that.

In fact, there are lymphoproliferative disorders that are defined by caspase mutations that lower their activity. So I'm not sure where the company is going with this.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up